HAP's Latest News

During National Hospital Week, HAP is revisiting its Caring for the Commonwealth video series, which highlights the many ways Pennsylvania hospitals are advancing care, supporting patients, and strengthening communities across the commonwealth. Patients rely on hospitals to deliver outstanding care when and where they need it, and Pennsylvania’s hospitals are rising to the occasion through innovation, community partnerships, and compassionate care.

Securing and maintaining a steady and satisfied workforce is every hospital’s challenge, and experts at Jefferson Health are thinking outside the box to find solutions.

National Hospital Week shines a spotlight on the many ways Pennsylvania’s hospitals and health systems are always there for the communities they serve.

Pennsylvania’s Department of Health (DOH) has been monitoring the spread of measles in Lebanon County, while emphasizing the importance of vaccination to prevent the virus.

Penn Highlands Healthcare is leveraging partnerships with local schools to promote health care careers to the next generation’s workforce. In 2025, the hospital launched its Healthcare in High School program to build a strong local workforce pipeline by introducing students to health care careers early.

CMS has approved Medicaid coverage for doula services, the Pennsylvania Department of Human Services announced last week.

The Pennsylvania House passed HAP-supported legislation Wednesday that establishes a pathway to licensure for Certified Midwives (CM) in Pennsylvania.

Leaders at Geisinger are being proactive in their approach to the ongoing workforce shortage. By creating a clear pathway from education to employment, hospitals can build the future health care workforce, according to Andrew Capalong, MSN, RN, system director of workforce development at Geisinger.

U.S. doctors face a growing risk of being sued even if no error occurred, and high medical liability insurance premiums increase costs across the health care system.

The FDA announced it’s looking to fast-track regulatory process for certain drugs that may help conditions like depression and post-traumatic stress disorder (PTSD) that have been notoriously difficult to treat.